Search
Showing results for "1"
News & Events
COVID Update August 2022We have been advised by the Department of Infectious Diseases at Perth Children's Hospital and the Wesfarmers Centre of Vaccines and Infectious Diseases at The Kids Research Institute Australia that COVID-19 vaccinations are now available for young children aged 6 months to 4 years with type 1 diabetes.
News & Events
Kids rock out at diabetes campKids living with Type 1 Diabetes were literally blown away when the Westpac Lifesaver Rescue Helicopter dropped in at the Diabetes WA and PMH kids' camp.
We know many families have questions about the risk of COVID-19 to children with type 1 diabetes. To address these questions, Perth Children’s Hospital’s Diabetes Clinic has provided information and resources to help you navigate this tricky period.
Research
A core outcome set to assess chronic pain interference and impact on emotional functioning for children and young people with cerebral palsyAim: To: (1) develop a core outcome set (COS) to assess chronic pain interference and impact on emotional functioning for children and young people with cerebral palsy (CP) with varying communication, cognitive, and functional abilities; (2) categorize the assessment tools according to reporting method or observer-reported outcome measures; and (3) categorize the content of tools in the COS according to the International Classification of Functioning, Disability and Health (ICF).
The WAACHS regional profiles look at all four volumes of results across the ATSIC regions of Western Australia.
Research
Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trialAboriginal children living in remote communities are at high risk of early and persistent otitis media. Streptococcus pneumoniae and non-typeable Haemophilus influenzae (NTHi) are primary pathogens. Vaccines with potential to prevent early OM have not been evaluated in this population. We compared immunogenicity (ELISA and opsonophagocytic activity) of a combination of Synflorix™ (PHiD-CV10, 10 serotypes and protein D of NTHi) and Prevenar13™ (PCV13, 10 serotypes plus 3, 6A, and 19A), with recommended schedules.
Research
Prenatal omega-3 LCPUFA and symptoms of allergic disease and sensitization throughout early childhoodMaternal supplementation with 900 mg of ω-3 LCPUFA did not change the progression of IgE-mediated allergic disease symptoms or sensitization
Research
Chronic cat allergen exposure induces a Th2 cell-dependent IgG4 response related to low sensitizationThis study evaluated the relationship between cat allergen–specific biomarkers in adults with cat allergy with and without cat ownership.
News & Events
Would you like to test our new exercise app?We have been working with young people with T1D, other researchers and app developers to create a new smartphone exercise app called acT1ve.
News & Events
Diabetes service celebrates 50th yearIt’s hard to believe that 20 years has passed since April Welsh, 5, was pictured with Professor Tim Jones in a story about type 1 diabetes research. Plenty has changed but one constant remains — Professor Jones still works for WA’s only paediatric diabetes service which celebrates its 50th year.